PerkinElmer gets FDA approval for T-Cell Select kit to automate TB test

PerkinElmer gets FDA approval for T-Cell Select kit to automate TB test

PerkinElmer’s Oxford Immunotec today announced that the U. S Food and Drug Administration had approved the use of the T-Cell Select reagent kit to automate its T-SPOT. The T-Cell Select reagent kit would allow for a more automated workflow. It is designed to reduce the hands-on time for lab personnel and lower overall costs. The increased use of automation would also improve blood sample logistics. It would allow for a standard blood collection tube, and it can be stored at room temperature for up to 54 hours with no complex phlebotomy practices.

The extended blood sample stability would enable easy centralization of sample processing which expands access to the T-SPOT. TB tests give laboratories more flexibility with the potential for sample batching.

T-Cell Select is called a peripheral blood mononuclear cell (PBMC) isolation reagent that uses a positive selection of PBMCs with magnetic bead-based cell separation to automate and simplify the preparations of cells for the T-SPOT. TB test is a globally regulated ELISPOT IGRA for detecting latent TB infection. The T-SPOT. TB test with the T –Cell Select reagent kit is known as the only automated IGRA TB test without regulatory warnings for immunocompromised patients who have lower levels of T-Cells available to evaluate.

The kit is also available throughout Europe, where CE marking is accepted, and it is quickly becoming available in more markets worldwide. Perkin Elmer is also known as the leading global provider of end-to-end solutions that would help scientists, researchers, and clinicians to better diagnose the disease, discover new and more personalized drugs, monitor the safety and the quality of the food and drive environmental and applied analysis excellence. They are also deeply committed to good corporate citizenship through their dynamic ESG and sustainability programs.

The Company also reported revenues of approximately $5 billion in 2021 and serves customers in 190 countries, and is a component of the S&P 500 index. It has a mission of innovating itself for a healthier world. It has a dedicated team of more than 16,000 collaborators working closely with commercial, government, academic, and healthcare customers.

Featured Image Credit: Clinical Lab Products

Leave a Reply

Your email address will not be published.